moDCs, Less Problems

Publication date: 16 January 2018
Source:Immunity, Volume 48, Issue 1
Author(s): Alycia Gardner, Brian Ruffell
Type 1 conventional dendritic cells are necessary for the development of anti-tumor immunity. In this issue of Immunity, Sharma et al. (2018) identify a phenotypically similar monocyte-derived population within inflamed tumors that promotes T cell responses during therapy.

Teaser

Type 1 conventional dendritic cells are necessary for the development of anti-tumor immunity. In this issue of Immunity, Sharma et al. (2018) identify a phenotypically similar monocyte-derived population within inflamed tumors that promotes T cell responses during therapy.


http://ift.tt/2CfOhsR